Clinical Trial Update: Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update discusses the incidence of hepatitis B reactivation in lymphoma patients who are HBsAg negative and HBcAb positive treated with the R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Fudan University | Conditions: Lymphoma | Phase 2, Phase 3 | Status: UNKNOWN